TRIGLYCERIDE-RICH LIPOPROTEIN INTERACTIONS WITH LP(A)

被引:23
作者
MCCONATHY, WJ
TRIEU, VN
KOREN, E
WANG, CS
CORDER, CC
机构
[1] GENET THERAPY INC,GAITHERSBURG,MD 20877
[2] OKLAHOMA MED RES FDN,OKLAHOMA CITY,OK 73104
关键词
LDL; INTERACTIONS; LIPOLYSIS; HYPERTRIGLYCERIDEMIA;
D O I
10.1016/0009-3084(94)90129-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found a significantly reduced incidence of increased lipoprotein(a) (Lp(a)) levels in subjects with triglycerides (TG) greater than 150 mg/dl compared with those with TG levels lower than 150 mg/dl. This was the case in patients with angiographically documented coronary artery disease (CAD) and in subjects with no CAD. We explored the potential role of lipoprotein lipase (LPL) in mediating this relationship. Lp(a) and LDL, exhibited a minimal effect on the rate constant for degradation of VLDL-TG by LPL (13% inhibition). Binding analyses indicated no differences between VLDL and LDL with respect to Lp(a) binding, and lipolysis only reduced binding by 30% at 75% degradation of VLDL-TG. Our study indicates that the inverse relationship between elevated plasma TG and Lp(a) levels is not caused by activation of LPL by Lp(a) either due to failure of Lp(a) to bind to VLDL or its lipolytic remnants. It is hypothesized that this relationship could stem from the enhanced clearance of TG-rich lipoproteins in individuals with higher levels of Lp(a) by receptor-mediated events.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 34 条
[1]  
ALBERS JJ, 1977, J LIPID RES, V18, P331
[2]   LP(A) LIPOPROTEIN - RELATIONSHIP TO SINKING PRE-BETA LIPOPROTEIN, HYPERLIPOPROTEINEMIA, AND APOLIPOPROTEIN-B [J].
ALBERS, JJ ;
CABANA, VG ;
WARNICK, GR ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (09) :1047-1054
[3]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[4]   FAT FEEDING IN HUMANS INDUCES LIPOPROTEINS OF DENSITY LESS THAN 1.006 THAT ARE ENRICHED IN APOLIPOPROTEIN [A] AND THAT CAUSE LIPID-ACCUMULATION IN MACROPHAGES [J].
BERSOT, TP ;
INNERARITY, TL ;
PITAS, RE ;
RALL, SC ;
WEISGRABER, KH ;
MAHLEY, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :622-630
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   PRONOUNCED LOWERING OF SERUM LEVELS OF LIPOPROTEIN LP(A) IN HYPERLIPEMIC SUBJECTS TREATED WITH NICOTINIC-ACID [J].
CARLSON, LA ;
HAMSTEN, A ;
ASPLUND, A .
JOURNAL OF INTERNAL MEDICINE, 1989, 226 (04) :271-276
[7]  
GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582
[8]  
GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P296
[9]   LIPOPROTEIN(A) MODULATION OF ENDOTHELIAL-CELL SURFACE FIBRINOLYSIS AND ITS POTENTIAL ROLE IN ATHEROSCLEROSIS [J].
HAJJAR, KA ;
GAVISH, D ;
BRESLOW, JL ;
NACHMAN, RL .
NATURE, 1989, 339 (6222) :303-305
[10]   USE OF AVIDIN-BIOTIN COMPLEX FOR LOCALIZATION OF ACTIN AND MYOSIN WITH FLUORESCENCE MICROSCOPY [J].
HEGGENESS, MH ;
ASH, JF .
JOURNAL OF CELL BIOLOGY, 1977, 73 (03) :783-788